Provectus Biopharmaceuticals, Inc. (PVCT)
OTCMKTS · Delayed Price · Currency is USD
0.0584
-0.0006 (-1.02%)
Jan 23, 2026, 3:28 PM EST

PVCT Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 20202015 - 2019
Period Ending
Jan '26 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2015 - 2019
255040452323
Upgrade
Market Cap Growth
-51.33%25.33%-11.35%96.93%-1.55%-5.21%
Upgrade
Enterprise Value
275343482346
Upgrade
Last Close Price
0.060.120.100.110.060.06
Upgrade
PS Ratio
70.0481.7972.2145.94--
Upgrade
PB Ratio
-3.98-8.46-5.30-7.29-5.51-0.78
Upgrade
EV/Sales Ratio
76.7986.0577.2548.64--
Upgrade
Debt / Equity Ratio
-0.40-0.53-0.40-0.35-0.42-0.79
Upgrade
Asset Turnover
0.570.500.320.36--
Upgrade
Quick Ratio
0.010.040.010.000.090.00
Upgrade
Current Ratio
0.040.140.150.230.450.01
Upgrade
Return on Assets (ROA)
-623.13%-200.92%-89.58%-64.62%-141.40%-298.62%
Upgrade
Return on Capital Employed (ROCE)
100.70%66.10%33.00%46.60%110.80%16.40%
Upgrade
Earnings Yield
-27.15%-9.44%-7.70%-7.82%-24.01%-28.50%
Upgrade
FCF Yield
--6.51%-6.39%-6.69%-4.39%-17.44%
Upgrade
Buyback Yield / Dilution
-0.16%-0.07%-0.01%-2.76%-3.81%-1.72%
Upgrade
Source: S&P Global Market Intelligence. Standard template. Financial Sources.